CRSP Rega marang bathi mangsa ngarep CRISPR Therapeutics Inc

Simbol resmi perusahaan CRISPR Therapeutics Inc (CRSP)

By creating unique genetic code correction methods to eradicate pathologies, CRISPR Therapeutics AG (CRSP) monetizes the exclusivity of its therapies through high pricing. The launch of Casgevy and partner payments are driving growth, while the company's forward 12-month P/E reflects market expectations, where the value of 0.00 serves as the current metric. This CRISPR/Cas9 leader is ushering in an era of DNA-level treatment for the global market.

Pangali mangsa ngarep rega marang bathi: CRISPR Therapeutics Inc (CRSP) kanggo 04.07.2022 - 18.11.2026

Rincian metrik komprehensif lan analitis CRISPR Therapeutics AG (CRSP)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:crisprtx.com
Sampel barang CRISPR

The forward P/E reflects the ratio of the current market share price to the expected earnings per share over the next twelve months, allowing for an assessment of the premium paid for future income. The trend of the expected NTM P/E for CRISPR Therapeutics AG (CRSP) demonstrates the valuation's sensitivity to revised earnings forecasts, which is critical for CRISPR Therapeutics AG (CRSP) amid the commercialization of Casgevy and the development of its innovative in vivo editing pipeline.

Pesaing CRISPR Therapeutics AG (CRSP)

Prakiraan rega marang bathi TEM (Tempus AI, Inc)|Qiagen Group (QGEN) - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep ionispharma.com IONS|Kapitalisasi marang proyeksi bathi Repligen Corporation (RGEN)|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi WGS (GeneDx)|RARE: Pangali Forward P/E|Beam Therapeutics Corp - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi SRPT|twistbioscience.com (TWST) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E TXG|NTLA (Intellia) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Stoke STOK|BioLife (BLFS) - Rasio prakiraan rega marang bathi|wavelifesciences.com - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake MAZE|SION: Pangali Forward P/E|PRME - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi TSHA|QURE - Pangali forward rega marang bathi|Pangali Forward P/E MGTX|Kapitalisasi marang proyeksi bathi regenxbio.com|Pangali Forward P/E SLDB (Solid Biosciences Inc)|OCGN: Rasio rega marang bathi mangsa ngarep|PACB - Rega marang bathi mangsa ngarep|Benitec (BNTC) - Prakiraan rega marang bathi|DSGN: Pangali Forward P/E|RCKT: Rasio kapitalisasi marang bathi mangsa ngarep|FDMT (4D Molecular Therapeutics, Inc.) - Pangali Forward P/E|lexeotx.com (LXEO) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E KRRO|Prakiraan rega marang bathi Editas Medicine, Inc. EDIT|Rega marang bathi mangsa ngarep silence-therapeutics.com SLN|PRQR: Rasio rega marang bathi mangsa ngarep|CDXS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Metagenomi, Inc. (MGX)|Prakiraan rega marang bathi DTIL|Rasio rega marang bathi mangsa ngarep GBIO (generationbio.com)|Rega marang bathi mangsa ngarep Boundless Bio, Inc (BOLD)|Pangali Forward P/E Exicure Inc. (XCUR)|Imunon, Inc. - Prakiraan rega marang bathi|PHIO: Rasio rega marang bathi mangsa ngarep|MBIO - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake RNAZ|Bionano Genomics, Inc. (BNGO) - Rega marang bathi mangsa ngarep|Applied DNA Sciences, Inc. (APDN) - Pangali Forward P/E|BLUE (bluebirdbio.com) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise Antibodies)|Pangali Forward P/E OMGA|Prakiraan rega marang bathi Singular Genomics Systems OMIC|Pangali Forward P/E RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON)|UBX: Pangali Forward P/E